Clinical Trial Update: The CHORAL Flow Study [Phase 4]

View source ↗

Summary

The CHORAL Flow Study, a Phase 4 clinical trial sponsored by Imperial College London, has been terminated. The conditions involved include coronary artery disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease
• Hyperlipidemia

Snippet

Sponsor: Imperial College London | Conditions: Coronary Artery Disease, Atherosclerosis | Phase 4 | Status: TERMINATED